Pharmacy

We’re only using a fraction of health workers’ skills. This needs to change

Retrieved on: 
Dienstag, April 23, 2024

That is, before the shift of education of nurses and other health professionals into universities in the 1980s.

Key Points: 
  • That is, before the shift of education of nurses and other health professionals into universities in the 1980s.
  • But the recently released paper from an independent Commonwealth review on health workers’ “scope of practice” identifies the myriad of barriers preventing Australians from fully benefiting from health professionals’ skills.
  • But we now have a sensible pathway to improve access to care, using all health professionals appropriately.

A new vision for general practice

  • To do this, I logged onto my general practice’s website, answered the question about what I wanted, booked an appointment with the practice nurse that afternoon, got jabbed, was bulk-billed, sat down for a while, and then went home.
  • The Commonwealth government has allowed the practice to be paid by Medicare for the nurse’s work.
  • The venture capitalist practice owner has done the sums and decided allocating a room to a practice nurse is economically rational.
  • It would be good if my general practice also had a physiotherapist, who I could see if I had back pain without seeing the GP, but there is no Medicare rebate for this.

How about pharmacists?

  • Pharmacy owners especially have argued that pharmacists should be able to practise independently of GPs, prescribing a limited range of medications and dispensing them.
  • This will inevitably reduce continuity of care and potentially create risks if the GP is not aware of what other medications a patient is using.
  • Paying pharmacists independent prescribing may be part of the next agreement, the details of which are currently being negotiated.
  • So their organisations highlight the risks of these changes, reopening centuries old turf wars dressed up as concerns about safety and risk.

Who pays for all this?

  • Clearly the government must increase its support for comprehensive general practice.
  • This should be the principal direction of primary care reform, and the final report of the scope of practice review should make that clear.
  • In parallel, governments – state and federal – must ensure all health professionals are used to their best of their abilities.
  • Read more:
    Pharmacists should be able to work with GPs to prescribe medicines for long-term conditions


Stephen Duckett was a member of the Strengthening Medicare Taskforce and is a member of the Commonwealth Department of Health's Expert Advisory Panel for the Review of General Practice Incentives

Proposed FTC Order will Prohibit Telehealth Firm Cerebral from Using or Disclosing Sensitive Data for Advertising Purposes, and Require it to Pay $7 Million

Retrieved on: 
Donnerstag, April 18, 2024

The order must be approved by the court before it can go into effect.

Key Points: 
  • The order must be approved by the court before it can go into effect.
  • “As the Commission’s complaint lays out, Cerebral violated its customers’ privacy by revealing their most sensitive mental health conditions across the Internet and in the mail,” said FTC Chair Lina M. Khan.
  • “To address this betrayal, the Commission is ordering a first-of-its-kind prohibition that bans Cerebral from using any health information for most advertising purposes."
  • Cerebral provides online mental health and related services on a negative option basis, which means consumers are automatically charged unless they cancel those services.
  • Despite promising that consumers could “cancel anytime,” Cerebral required its clients to navigate a complex, multi-step, and often multi-day process to cancel.
  • The complaint alleges that the company continued to charge consumers while it slow-walked consumers’ cancellation requests, which cost consumers millions in additional charges.
  • The proposed order, which must be approved by a federal court before it can go into effect, only applies to Cerebral.
  • The Commission voted 3-0 to refer the complaint against Cerebral and Robertson and a stipulated final order with Cerebral to the Department of Justice for filing.
  • The DOJ filed the complaint and stipulated order in the U.S. District Court for the Southern District of Florida.

How “location, location, location” can lead to “enforcement, enforcement, enforcement”

Retrieved on: 
Freitag, April 12, 2024

How “location, location, location” can lead to “enforcement, enforcement, enforcement”

Key Points: 

How “location, location, location” can lead to “enforcement, enforcement, enforcement”

Infections after surgery are more likely due to bacteria already on your skin than from microbes in the hospital − new research

Retrieved on: 
Mittwoch, April 10, 2024

Genetic data from the bacteria causing these infections – think CSI for E. coli – tells another story: Most health care-associated infections are caused by previously harmless bacteria that patients already had on their bodies before they even entered the hospital.

Key Points: 
  • Genetic data from the bacteria causing these infections – think CSI for E. coli – tells another story: Most health care-associated infections are caused by previously harmless bacteria that patients already had on their bodies before they even entered the hospital.
  • We show that many surgical site infections after spinal surgery are caused by microbes that are already on the patient’s skin.

Surgical infections are a persistent problem

  • Among the different types of heath care-associated infections, surgical site infections stand out as particularly problematic.
  • A 2013 study found that surgical site infections contribute the most to the annual costs of hospital-acquired infections, totaling over 33% of the US$9.8 billion spent annually.
  • Still, surgical site infections occur following about 1 in 30 procedures, typically with no explanation.
  • While rates of many other medical complications have shown steady improvement over time, data from the Agency for Healthcare Research and Quality and the Centers for Disease Control and Prevention show that the problem of surgical site infection is not getting better.

BYOB (Bring your own bacteria)

  • Prior studies on surgical site infection have been limited to a single species of bacteria and used older genetic analysis methods.
  • But new technologies have opened the door to studying all types of bacteria and testing their antibiotic resistance genes simultaneously.
  • Over a one-year period, we sampled the bacteria living in the nose, skin and stool of over 200 patients before surgery.
  • In fact, 86% of the bacteria causing infections after spine surgery were genetically matched to bacteria a patient carried before surgery.
  • That number is remarkably close to estimates from earlier studies using older genetic techniques focused on Staphylococcus aureus.
  • They likely acquired these antibiotic-resistant microbes through prior antibiotic exposure, consumer products or routine community contact.

Preventing surgical infections

  • At face value, our results may seem intuitive – surgical wound infections come from bacteria that hang out around that part of the body.
  • If the most likely source of surgical infection – the patient’s microbiome – is known in advance, this presents medical teams with an opportunity to protect against it prior to a scheduled procedure.
  • The fact that most infections don’t actually start with sources in the hospital is probably a testament to the efficacy of these protocols.


Dustin Long receives funding from the National Institutes of Health. Dr Bryson-Cahn receives funding from the Gordon and Berry Moore Foundation and is the co-medical director for Alaska Airlines.

EQS-News: Marinomed Biotech AG enters new Carragelose distribution partnerships for Gulf region and Eastern Europe

Retrieved on: 
Mittwoch, April 10, 2024

Korneuburg, Austria, 26 March 2024 – Marinomed Biotech AG (VSE:MARI) has entered into partnerships with GAIA Healthcare FZ LLC and VitaPlus Kft for the distribution of Carragelose nasal sprays.

Key Points: 
  • Korneuburg, Austria, 26 March 2024 – Marinomed Biotech AG (VSE:MARI) has entered into partnerships with GAIA Healthcare FZ LLC and VitaPlus Kft for the distribution of Carragelose nasal sprays.
  • GAIA Healthcare, a renowned pharmaceutical marketing and distribution company based in the United Arab Emirates, has secured the rights to market two different Carragelose nasal sprays in the Gulf region.
  • Furthermore, Marinomed has expanded its reach in selected Eastern European countries by entering a distribution partnership with VitaPlus, a Hungarian company owned by Belgium-based Ceres Pharma.
  • “Overall, we are pleased with the development of our Carragelose business by expanding our geographical reach to interesting pharmaceuticals markets like the Gulf Region and Eastern Europe.

EQS-News: Strong start of the year for Redcare Pharmacy, double-digit sales growth continues.

Retrieved on: 
Mittwoch, April 10, 2024

Strong start of the year for Redcare Pharmacy, double-digit sales growth continues.

Key Points: 
  • Strong start of the year for Redcare Pharmacy, double-digit sales growth continues.
  • Redcare Pharmacy’s CEO, Olaf Heinrich comments: “We started the year very well, with strong sales growth accompanied by persistently high non-financial KPIs.
  • Non-Rx sales growth was 16.8% to EUR 297 million (Q1 2023: EUR 254 million), while prescription medication sales (Rx) rose by 348.3% to EUR 156 million.
  • Excluding MediService, Rx sales growth in DACH was 6.8% to EUR 37 million (Q1 2023: EUR 35 million).

Valbiotis to launch its 100% natural dietary supplement for the management of hypercholesterolemia on the French market in May

Retrieved on: 
Mittwoch, April 10, 2024

The natural and innovative characteristics of this product clearly position Valbiotis®PRO Cholestérol as a leader in the lifestyle and dietary management of hypercholesterolemia, a major risk factor for cardiovascular disease."

Key Points: 
  • The natural and innovative characteristics of this product clearly position Valbiotis®PRO Cholestérol as a leader in the lifestyle and dietary management of hypercholesterolemia, a major risk factor for cardiovascular disease."
  • Available behind the counter in pharmacies, the dietary supplement will also be sold without a prescription with a pharmacist’s recommendation.
  • It comprises a new generation of dietary supplements with active ingredients of natural origin, acting on several targets for comprehensive management.
  • A principal mechanism controls intestinal cholesterol absorption, while a complementary mechanism acts on hepatic metabolism for a comprehensive approach to the management of hypercholesterolemia.

EQS-News: Medios acquires Dutch market leader in pharmaceutical compounding services

Retrieved on: 
Mittwoch, April 10, 2024

Ceban is the Dutch market leader in compounding and has growing market positions in Belgium and Spain.

Key Points: 
  • Ceban is the Dutch market leader in compounding and has growing market positions in Belgium and Spain.
  • The purchase price for 100% of Ceban shares includes a cash component of €235.3 million and 1.7 million Medios shares.
  • The acquisition of Ceban gives Medios an outstanding position in the Dutch pharmaceutical market.
  • Ceban has a market leading position in pharmaceutical compounding in the Netherlands, a top-3 position in Belgium and a top-5 position in Spain.

CareRx to Present at 2024 Bloom Burton & Co. Healthcare Investor Conference on Wednesday, April 17, 2024

Retrieved on: 
Donnerstag, April 4, 2024

Mr. Khanna's presentation is scheduled for Wednesday, April 17, 2024, at 3:00 pm ET.

Key Points: 
  • Mr. Khanna's presentation is scheduled for Wednesday, April 17, 2024, at 3:00 pm ET.
  • Investors interested in meeting with CareRx during the conference should contact Bloom Burton & Co.'s conference coordinator.
  • The Bloom Burton & Co. Healthcare Investor Conference brings together U.S., Canadian and international investors who are interested in the latest developments in the Canadian healthcare sector.
  • Attendees will have an opportunity to obtain corporate updates from the premier Canadian publicly traded and private companies through presentations and private meetings.